May 06, 2020
Foundation for Sarcoidosis Research and University of Cincinnati Share Initial Results of COVID-19 Impact Survey
May 05, 2020
Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
May 05, 2020
The Myositis Association Takes the Lead in Rare Disease in Virtual Community Building and Empowering the Patient through Telemedicine
Apr 25, 2020
Advisory - Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician
Apr 21, 2020
Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder
Apr 21, 2020
Multiple Sclerosis Drugs Industry Assessment 2020: Immunomodulators, Immunosuppressants, Interferons and Others
Apr 21, 2020
Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE) Study
Apr 20, 2020
COVID-19 Update - Hydroxychloroquine Market was Estimated to be US$ 41.3 Mn in 2018 and is Growing at a CAGR of 10.4% Over the Forecast Period, Owing to Increasing Demand for Medications to Treat Autoimmune Diseases, Says Absolute Markets Insights
Apr 20, 2020
Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis
Apr 17, 2020
Insulin Co-Pays Capped at $100 for People with Diabetes in Washington
Apr 16, 2020
InDex Pharmaceuticals Advances Cobitolimod Further Towards Phase III Following Successful Interactions With FDA and EMA
Apr 15, 2020
FDA Grants Fast Track Designation to RemeGen's Telitacicept as a Treatment for Systemic Lupus Erythematosus
Apr 15, 2020
Mallinckrodt Announces Publication of Data on Acthar® Gel (Repository Corticotropin Injection) from its Randomized, Double-Blind, Placebo-Controlled Phase 4 Study in Rheumatoid Arthritis (RA) in Rheumatology and Therapy
Apr 14, 2020
Research Among People Living With Lupus Finds Widespread, Under-Addressed Anxiety and Depression
Apr 10, 2020
Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets(TM)
Apr 09, 2020
Hydroxychloroquine, Lupus and COVID-19: What We've Learned and What's Next?
Apr 09, 2020
Crohn's & Colitis Foundation Welcomes New National Trustees
Apr 09, 2020
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
Apr 08, 2020
Alopecia Industry Growth Opportunities, 2020-2027 - Increasing Prevalence of Diseases Across the Globe, Technological Progression, Growth in Per-Capita Expenditures Toward Healthcare
Apr 07, 2020
Lupus Therapeutics, Affiliate Of Lupus Research Alliance, Developing A Study Focused On Lupus Patients And COVID-19